ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Perfluorodecalin for Ophthalmic Surgery Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: October 2025
|
Report Code: QYRE-Auto-8N17635
Home | Market Reports | Health| Vision Care
Global Perfluorodecalin for Ophthalmic Surgery Market Research Report 2024
BUY CHAPTERS

Global Perfluorodecalin for Ophthalmic Surgery Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-8N17635
Report
October 2025
Pages:138
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Alchimia
Bausch & Lomb
BVI Medical
Geuder AG
Micromed
Pharmpur
Toomac Ophthalmic
Bausch & Lomb

Perfluorodecalin for Ophthalmic Surgery Market

The global Perfluorodecalin for Ophthalmic Surgery market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Perfluorodecalin for ophthalmic surgery is a perfluorocarbon aromatic organic compound. At room temperature, it is a colorless, odorless, non-toxic liquid with a low boiling point and a high boiling point. It can be used to fix and protect the eyeball during ophthalmic surgery.
From a downstream perspective, Hospital accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Perfluorodecalin for Ophthalmic Surgery leading manufacturers including Alchimia srl, Bausch + Lomb, BVI Medical, Geuder AG, Pharmpur, Toomac Ophthalmic, Micromed srl, etc., dominate supply; the top five capture approximately % of global revenue, with Alchimia srl leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Perfluorodecalin for Ophthalmic Surgery market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Perfluorodecalin for Ophthalmic Surgery Market Report

Report Metric Details
Report Name Perfluorodecalin for Ophthalmic Surgery Market
Segment by Type
  • Purity ≥ 95%
  • Purity ≥ 97%
Segment by Application
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Alchimia srl, Bausch + Lomb, BVI Medical, Geuder AG, Pharmpur, Toomac Ophthalmic, Micromed srl
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Perfluorodecalin for Ophthalmic Surgery study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Perfluorodecalin for Ophthalmic Surgery Market report?

Ans: The main players in the Perfluorodecalin for Ophthalmic Surgery Market are Alchimia srl, Bausch + Lomb, BVI Medical, Geuder AG, Pharmpur, Toomac Ophthalmic, Micromed srl

What are the Application segmentation covered in the Perfluorodecalin for Ophthalmic Surgery Market report?

Ans: The Applications covered in the Perfluorodecalin for Ophthalmic Surgery Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Perfluorodecalin for Ophthalmic Surgery Market report?

Ans: The Types covered in the Perfluorodecalin for Ophthalmic Surgery Market report are Purity ≥ 95%, Purity ≥ 97%

Recommended Reports

Ophthalmic Devices

Ophthalmic Pharmaceuticals

Perfluorinated Compounds

1 Study Coverage
1.1 Introduction to Perfluorodecalin for Ophthalmic Surgery: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Perfluorodecalin for Ophthalmic Surgery Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Purity ≥ 95%
1.2.3 Purity ≥ 97%
1.3 Market Segmentation by Application
1.3.1 Global Perfluorodecalin for Ophthalmic Surgery Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Perfluorodecalin for Ophthalmic Surgery Revenue Estimates and Forecasts 2020-2031
2.2 Global Perfluorodecalin for Ophthalmic Surgery Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Perfluorodecalin for Ophthalmic Surgery Sales Estimates and Forecasts 2020-2031
2.4 Global Perfluorodecalin for Ophthalmic Surgery Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Perfluorodecalin for Ophthalmic Surgery Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Perfluorodecalin for Ophthalmic Surgery Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Purity ≥ 95% Market Size by Manufacturers
3.5.2 Purity ≥ 97% Market Size by Manufacturers
3.6 Global Perfluorodecalin for Ophthalmic Surgery Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Perfluorodecalin for Ophthalmic Surgery Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Perfluorodecalin for Ophthalmic Surgery Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Perfluorodecalin for Ophthalmic Surgery Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Perfluorodecalin for Ophthalmic Surgery Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Perfluorodecalin for Ophthalmic Surgery Sales and Revenue by Type (2020-2031)
6.4 North America Perfluorodecalin for Ophthalmic Surgery Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Perfluorodecalin for Ophthalmic Surgery Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Perfluorodecalin for Ophthalmic Surgery Sales and Revenue by Type (2020-2031)
7.4 Europe Perfluorodecalin for Ophthalmic Surgery Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Perfluorodecalin for Ophthalmic Surgery Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Perfluorodecalin for Ophthalmic Surgery Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Perfluorodecalin for Ophthalmic Surgery Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Perfluorodecalin for Ophthalmic Surgery Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Perfluorodecalin for Ophthalmic Surgery Sales and Revenue by Type (2020-2031)
9.4 Central and South America Perfluorodecalin for Ophthalmic Surgery Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Perfluorodecalin for Ophthalmic Surgery Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Perfluorodecalin for Ophthalmic Surgery Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Perfluorodecalin for Ophthalmic Surgery Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Perfluorodecalin for Ophthalmic Surgery Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Alchimia srl
11.1.1 Alchimia srl Corporation Information
11.1.2 Alchimia srl Business Overview
11.1.3 Alchimia srl Perfluorodecalin for Ophthalmic Surgery Product Models, Descriptions and Specifications
11.1.4 Alchimia srl Perfluorodecalin for Ophthalmic Surgery Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Alchimia srl Perfluorodecalin for Ophthalmic Surgery Sales by Product in 2024
11.1.6 Alchimia srl Perfluorodecalin for Ophthalmic Surgery Sales by Application in 2024
11.1.7 Alchimia srl Perfluorodecalin for Ophthalmic Surgery Sales by Geographic Area in 2024
11.1.8 Alchimia srl Perfluorodecalin for Ophthalmic Surgery SWOT Analysis
11.1.9 Alchimia srl Recent Developments
11.2 Bausch + Lomb
11.2.1 Bausch + Lomb Corporation Information
11.2.2 Bausch + Lomb Business Overview
11.2.3 Bausch + Lomb Perfluorodecalin for Ophthalmic Surgery Product Models, Descriptions and Specifications
11.2.4 Bausch + Lomb Perfluorodecalin for Ophthalmic Surgery Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Bausch + Lomb Perfluorodecalin for Ophthalmic Surgery Sales by Product in 2024
11.2.6 Bausch + Lomb Perfluorodecalin for Ophthalmic Surgery Sales by Application in 2024
11.2.7 Bausch + Lomb Perfluorodecalin for Ophthalmic Surgery Sales by Geographic Area in 2024
11.2.8 Bausch + Lomb Perfluorodecalin for Ophthalmic Surgery SWOT Analysis
11.2.9 Bausch + Lomb Recent Developments
11.3 BVI Medical
11.3.1 BVI Medical Corporation Information
11.3.2 BVI Medical Business Overview
11.3.3 BVI Medical Perfluorodecalin for Ophthalmic Surgery Product Models, Descriptions and Specifications
11.3.4 BVI Medical Perfluorodecalin for Ophthalmic Surgery Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 BVI Medical Perfluorodecalin for Ophthalmic Surgery Sales by Product in 2024
11.3.6 BVI Medical Perfluorodecalin for Ophthalmic Surgery Sales by Application in 2024
11.3.7 BVI Medical Perfluorodecalin for Ophthalmic Surgery Sales by Geographic Area in 2024
11.3.8 BVI Medical Perfluorodecalin for Ophthalmic Surgery SWOT Analysis
11.3.9 BVI Medical Recent Developments
11.4 Geuder AG
11.4.1 Geuder AG Corporation Information
11.4.2 Geuder AG Business Overview
11.4.3 Geuder AG Perfluorodecalin for Ophthalmic Surgery Product Models, Descriptions and Specifications
11.4.4 Geuder AG Perfluorodecalin for Ophthalmic Surgery Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Geuder AG Perfluorodecalin for Ophthalmic Surgery Sales by Product in 2024
11.4.6 Geuder AG Perfluorodecalin for Ophthalmic Surgery Sales by Application in 2024
11.4.7 Geuder AG Perfluorodecalin for Ophthalmic Surgery Sales by Geographic Area in 2024
11.4.8 Geuder AG Perfluorodecalin for Ophthalmic Surgery SWOT Analysis
11.4.9 Geuder AG Recent Developments
11.5 Pharmpur
11.5.1 Pharmpur Corporation Information
11.5.2 Pharmpur Business Overview
11.5.3 Pharmpur Perfluorodecalin for Ophthalmic Surgery Product Models, Descriptions and Specifications
11.5.4 Pharmpur Perfluorodecalin for Ophthalmic Surgery Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Pharmpur Perfluorodecalin for Ophthalmic Surgery Sales by Product in 2024
11.5.6 Pharmpur Perfluorodecalin for Ophthalmic Surgery Sales by Application in 2024
11.5.7 Pharmpur Perfluorodecalin for Ophthalmic Surgery Sales by Geographic Area in 2024
11.5.8 Pharmpur Perfluorodecalin for Ophthalmic Surgery SWOT Analysis
11.5.9 Pharmpur Recent Developments
11.6 Toomac Ophthalmic
11.6.1 Toomac Ophthalmic Corporation Information
11.6.2 Toomac Ophthalmic Business Overview
11.6.3 Toomac Ophthalmic Perfluorodecalin for Ophthalmic Surgery Product Models, Descriptions and Specifications
11.6.4 Toomac Ophthalmic Perfluorodecalin for Ophthalmic Surgery Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Toomac Ophthalmic Recent Developments
11.7 Micromed srl
11.7.1 Micromed srl Corporation Information
11.7.2 Micromed srl Business Overview
11.7.3 Micromed srl Perfluorodecalin for Ophthalmic Surgery Product Models, Descriptions and Specifications
11.7.4 Micromed srl Perfluorodecalin for Ophthalmic Surgery Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Micromed srl Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Perfluorodecalin for Ophthalmic Surgery Industry Chain
12.2 Perfluorodecalin for Ophthalmic Surgery Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Perfluorodecalin for Ophthalmic Surgery Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Perfluorodecalin for Ophthalmic Surgery Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Perfluorodecalin for Ophthalmic Surgery Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Perfluorodecalin for Ophthalmic Surgery Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
Alchimia
Bausch & Lomb
BVI Medical
Geuder AG
Micromed
Pharmpur
Toomac Ophthalmic
Bausch & Lomb
List of Tables
 Table 1. Global Perfluorodecalin for Ophthalmic Surgery Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Perfluorodecalin for Ophthalmic Surgery Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Perfluorodecalin for Ophthalmic Surgery Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Perfluorodecalin for Ophthalmic Surgery Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Perfluorodecalin for Ophthalmic Surgery Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Perfluorodecalin for Ophthalmic Surgery Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
 Table 7. Global Perfluorodecalin for Ophthalmic Surgery Sales by Region (2020-2025) & (K Units)
 Table 8. Global Perfluorodecalin for Ophthalmic Surgery Sales by Region (2026-2031) & (K Units)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Perfluorodecalin for Ophthalmic Surgery Sales by Manufacturers (2020-2025) & (K Units)
 Table 11. Global Perfluorodecalin for Ophthalmic Surgery Sales Share by Manufacturers (2020-2025)
 Table 12. Global Perfluorodecalin for Ophthalmic Surgery Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 13. Global Perfluorodecalin for Ophthalmic Surgery Revenue Market Share by Manufacturers (2020-2025)
 Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 15. Global Perfluorodecalin for Ophthalmic Surgery by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Perfluorodecalin for Ophthalmic Surgery as of 2024)
 Table 16. Global Perfluorodecalin for Ophthalmic Surgery Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 17. Global Perfluorodecalin for Ophthalmic Surgery Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
 Table 18. Key Manufacturers Perfluorodecalin for Ophthalmic Surgery Manufacturing Base and Headquarters
 Table 19. Global Perfluorodecalin for Ophthalmic Surgery Market Concentration Ratio (CR5 and HHI)
 Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 22. Global Perfluorodecalin for Ophthalmic Surgery Sales by Type (2020-2025) & (K Units)
 Table 23. Global Perfluorodecalin for Ophthalmic Surgery Sales by Type (2026-2031) & (K Units)
 Table 24. Global Perfluorodecalin for Ophthalmic Surgery Revenue by Type (2020-2025) & (US$ Million)
 Table 25. Global Perfluorodecalin for Ophthalmic Surgery Revenue by Type (2026-2031) & (US$ Million)
 Table 26. Global Perfluorodecalin for Ophthalmic Surgery ASP by Type (2020-2031) & (US$/Unit)
 Table 27. Technical Specifications by Key Product Type
 Table 28. Global Perfluorodecalin for Ophthalmic Surgery Sales by Application (2020-2025) & (K Units)
 Table 29. Global Perfluorodecalin for Ophthalmic Surgery Sales by Application (2026-2031) & (K Units)
 Table 30. Perfluorodecalin for Ophthalmic Surgery High-Growth Sectors Demand CAGR (2024-2031)
 Table 31. Global Perfluorodecalin for Ophthalmic Surgery Revenue by Application (2020-2025) & (US$ Million)
 Table 32. Global Perfluorodecalin for Ophthalmic Surgery Revenue by Application (2026-2031) & (US$ Million)
 Table 33. Global Perfluorodecalin for Ophthalmic Surgery ASP by Application (2020-2031) & (US$/Unit)
 Table 34. Top Customers by Region
 Table 35. Top Customers by Application
 Table 36. North America Perfluorodecalin for Ophthalmic Surgery Growth Accelerators and Market Barriers
 Table 37. North America Perfluorodecalin for Ophthalmic Surgery Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 38. North America Perfluorodecalin for Ophthalmic Surgery Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 39. Europe Perfluorodecalin for Ophthalmic Surgery Growth Accelerators and Market Barriers
 Table 40. Europe Perfluorodecalin for Ophthalmic Surgery Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Europe Perfluorodecalin for Ophthalmic Surgery Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 42. Asia-Pacific Perfluorodecalin for Ophthalmic Surgery Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Asia-Pacific Perfluorodecalin for Ophthalmic Surgery Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 44. Asia-Pacific Perfluorodecalin for Ophthalmic Surgery Growth Accelerators and Market Barriers
 Table 45. Southeast Asia Perfluorodecalin for Ophthalmic Surgery Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Central and South America Perfluorodecalin for Ophthalmic Surgery Investment Opportunities and Key Challenges
 Table 47. Central and South America Perfluorodecalin for Ophthalmic Surgery Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 48. Middle East and Africa Perfluorodecalin for Ophthalmic Surgery Investment Opportunities and Key Challenges
 Table 49. Middle East and Africa Perfluorodecalin for Ophthalmic Surgery Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 50. Alchimia srl Corporation Information
 Table 51. Alchimia srl Description and Major Businesses
 Table 52. Alchimia srl Product Models, Descriptions and Specifications
 Table 53. Alchimia srl Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 54. Alchimia srl Sales Value Proportion by Product in 2024
 Table 55. Alchimia srl Sales Value Proportion by Application in 2024
 Table 56. Alchimia srl Sales Value Proportion by Geographic Area in 2024
 Table 57. Alchimia srl Perfluorodecalin for Ophthalmic Surgery SWOT Analysis
 Table 58. Alchimia srl Recent Developments
 Table 59. Bausch + Lomb Corporation Information
 Table 60. Bausch + Lomb Description and Major Businesses
 Table 61. Bausch + Lomb Product Models, Descriptions and Specifications
 Table 62. Bausch + Lomb Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 63. Bausch + Lomb Sales Value Proportion by Product in 2024
 Table 64. Bausch + Lomb Sales Value Proportion by Application in 2024
 Table 65. Bausch + Lomb Sales Value Proportion by Geographic Area in 2024
 Table 66. Bausch + Lomb Perfluorodecalin for Ophthalmic Surgery SWOT Analysis
 Table 67. Bausch + Lomb Recent Developments
 Table 68. BVI Medical Corporation Information
 Table 69. BVI Medical Description and Major Businesses
 Table 70. BVI Medical Product Models, Descriptions and Specifications
 Table 71. BVI Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 72. BVI Medical Sales Value Proportion by Product in 2024
 Table 73. BVI Medical Sales Value Proportion by Application in 2024
 Table 74. BVI Medical Sales Value Proportion by Geographic Area in 2024
 Table 75. BVI Medical Perfluorodecalin for Ophthalmic Surgery SWOT Analysis
 Table 76. BVI Medical Recent Developments
 Table 77. Geuder AG Corporation Information
 Table 78. Geuder AG Description and Major Businesses
 Table 79. Geuder AG Product Models, Descriptions and Specifications
 Table 80. Geuder AG Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 81. Geuder AG Sales Value Proportion by Product in 2024
 Table 82. Geuder AG Sales Value Proportion by Application in 2024
 Table 83. Geuder AG Sales Value Proportion by Geographic Area in 2024
 Table 84. Geuder AG Perfluorodecalin for Ophthalmic Surgery SWOT Analysis
 Table 85. Geuder AG Recent Developments
 Table 86. Pharmpur Corporation Information
 Table 87. Pharmpur Description and Major Businesses
 Table 88. Pharmpur Product Models, Descriptions and Specifications
 Table 89. Pharmpur Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 90. Pharmpur Sales Value Proportion by Product in 2024
 Table 91. Pharmpur Sales Value Proportion by Application in 2024
 Table 92. Pharmpur Sales Value Proportion by Geographic Area in 2024
 Table 93. Pharmpur Perfluorodecalin for Ophthalmic Surgery SWOT Analysis
 Table 94. Pharmpur Recent Developments
 Table 95. Toomac Ophthalmic Corporation Information
 Table 96. Toomac Ophthalmic Description and Major Businesses
 Table 97. Toomac Ophthalmic Product Models, Descriptions and Specifications
 Table 98. Toomac Ophthalmic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 99. Toomac Ophthalmic Recent Developments
 Table 100. Micromed srl Corporation Information
 Table 101. Micromed srl Description and Major Businesses
 Table 102. Micromed srl Product Models, Descriptions and Specifications
 Table 103. Micromed srl Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 104. Micromed srl Recent Developments
 Table 105. Key Raw Materials Distribution
 Table 106. Raw Materials Key Suppliers
 Table 107. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 108. Milestones in Production Technology Evolution
 Table 109. Distributors List
 Table 110. Market Trends and Market Evolution
 Table 111. Market Drivers and Opportunities
 Table 112. Market Challenges, Risks, and Restraints
 Table 113. Research Programs/Design for This Report
 Table 114. Key Data Information from Secondary Sources
 Table 115. Key Data Information from Primary Sources


List of Figures
 Figure 1. Perfluorodecalin for Ophthalmic Surgery Product Picture
 Figure 2. Global Perfluorodecalin for Ophthalmic Surgery Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Purity ≥ 95% Product Picture
 Figure 4. Purity ≥ 97% Product Picture
 Figure 5. Global Perfluorodecalin for Ophthalmic Surgery Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 6. Hospital
 Figure 7. Clinic
 Figure 8. Others
 Figure 9. Perfluorodecalin for Ophthalmic Surgery Report Years Considered
 Figure 10. Global Perfluorodecalin for Ophthalmic Surgery Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Perfluorodecalin for Ophthalmic Surgery Revenue (2020-2031) & (US$ Million)
 Figure 12. Global Perfluorodecalin for Ophthalmic Surgery Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 13. Global Perfluorodecalin for Ophthalmic Surgery Revenue Market Share by Region (2020-2031)
 Figure 14. Global Perfluorodecalin for Ophthalmic Surgery Sales (2020-2031) & (K Units)
 Figure 15. Global Perfluorodecalin for Ophthalmic Surgery Sales (CAGR) by Region (2020-2031) (K Units)
 Figure 16. Global Perfluorodecalin for Ophthalmic Surgery Sales Market Share by Region (2020-2031)
 Figure 17. Top 5 and Top 10 Manufacturers Perfluorodecalin for Ophthalmic Surgery Sales Volume Market Share in 2024
 Figure 18. Global Perfluorodecalin for Ophthalmic Surgery Revenue Market Share Ranking (2024)
 Figure 19. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 20. Purity ≥ 95% Revenue Market Share by Manufacturer in 2024
 Figure 21. Purity ≥ 97% Revenue Market Share by Manufacturer in 2024
 Figure 22. Global Perfluorodecalin for Ophthalmic Surgery Sales Market Share by Type (2020-2031)
 Figure 23. Global Perfluorodecalin for Ophthalmic Surgery Revenue Market Share by Type (2020-2031)
 Figure 24. Global Perfluorodecalin for Ophthalmic Surgery Sales Market Share by Application (2020-2031)
 Figure 25. Global Perfluorodecalin for Ophthalmic Surgery Revenue Market Share by Application (2020-2031)
 Figure 26. North America Perfluorodecalin for Ophthalmic Surgery Sales YoY (2020-2031) & (K Units)
 Figure 27. North America Perfluorodecalin for Ophthalmic Surgery Revenue YoY (2020-2031) & (US$ Million)
 Figure 28. North America Top 5 Manufacturers Perfluorodecalin for Ophthalmic Surgery Sales Revenue (US$ Million) in 2024
 Figure 29. North America Perfluorodecalin for Ophthalmic Surgery Sales Volume (K Units) by Type (2020- 2031)
 Figure 30. North America Perfluorodecalin for Ophthalmic Surgery Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 31. North America Perfluorodecalin for Ophthalmic Surgery Sales Volume (K Units) by Application (2020-2031)
 Figure 32. North America Perfluorodecalin for Ophthalmic Surgery Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 33. US Perfluorodecalin for Ophthalmic Surgery Revenue (2020-2031) & (US$ Million)
 Figure 34. Canada Perfluorodecalin for Ophthalmic Surgery Revenue (2020-2031) & (US$ Million)
 Figure 35. Mexico Perfluorodecalin for Ophthalmic Surgery Revenue (2020-2031) & (US$ Million)
 Figure 36. Europe Perfluorodecalin for Ophthalmic Surgery Sales YoY (2020-2031) & (K Units)
 Figure 37. Europe Perfluorodecalin for Ophthalmic Surgery Revenue YoY (2020-2031) & (US$ Million)
 Figure 38. Europe Top 5 Manufacturers Perfluorodecalin for Ophthalmic Surgery Sales Revenue (US$ Million) in 2024
 Figure 39. Europe Perfluorodecalin for Ophthalmic Surgery Sales Volume (K Units) by Type (2020-2031)
 Figure 40. Europe Perfluorodecalin for Ophthalmic Surgery Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 41. Europe Perfluorodecalin for Ophthalmic Surgery Sales Volume (K Units) by Application (2020-2031)
 Figure 42. Europe Perfluorodecalin for Ophthalmic Surgery Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 43. Germany Perfluorodecalin for Ophthalmic Surgery Revenue (2020-2031) & (US$ Million)
 Figure 44. France Perfluorodecalin for Ophthalmic Surgery Revenue (2020-2031) & (US$ Million)
 Figure 45. U.K. Perfluorodecalin for Ophthalmic Surgery Revenue (2020-2031) & (US$ Million)
 Figure 46. Italy Perfluorodecalin for Ophthalmic Surgery Revenue (2020-2031) & (US$ Million)
 Figure 47. Russia Perfluorodecalin for Ophthalmic Surgery Revenue (2020-2031) & (US$ Million)
 Figure 48. Asia-Pacific Perfluorodecalin for Ophthalmic Surgery Sales YoY (2020-2031) & (K Units)
 Figure 49. Asia-Pacific Perfluorodecalin for Ophthalmic Surgery Revenue YoY (2020-2031) & (US$ Million)
 Figure 50. Asia-Pacific Top 8 Manufacturers Perfluorodecalin for Ophthalmic Surgery Sales Revenue (US$ Million) in 2024
 Figure 51. Asia-Pacific Perfluorodecalin for Ophthalmic Surgery Sales Volume (K Units) by Type (2020- 2031)
 Figure 52. Asia-Pacific Perfluorodecalin for Ophthalmic Surgery Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 53. Asia-Pacific Perfluorodecalin for Ophthalmic Surgery Sales Volume (K Units) by Application (2020-2031)
 Figure 54. Asia-Pacific Perfluorodecalin for Ophthalmic Surgery Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 55. Indonesia Perfluorodecalin for Ophthalmic Surgery Revenue (2020-2031) & (US$ Million)
 Figure 56. Japan Perfluorodecalin for Ophthalmic Surgery Revenue (2020-2031) & (US$ Million)
 Figure 57. South Korea Perfluorodecalin for Ophthalmic Surgery Revenue (2020-2031) & (US$ Million)
 Figure 58. China Taiwan Perfluorodecalin for Ophthalmic Surgery Revenue (2020-2031) & (US$ Million)
 Figure 59. India Perfluorodecalin for Ophthalmic Surgery Revenue (2020-2031) & (US$ Million)
 Figure 60. Central and South America Perfluorodecalin for Ophthalmic Surgery Sales YoY (2020-2031) & (K Units)
 Figure 61. Central and South America Perfluorodecalin for Ophthalmic Surgery Revenue YoY (2020-2031) & (US$ Million)
 Figure 62. Central and South America Top 5 Manufacturers Perfluorodecalin for Ophthalmic Surgery Sales Revenue (US$ Million) in 2024
 Figure 63. Central and South America Perfluorodecalin for Ophthalmic Surgery Sales Volume (K Units) by Type (2021-2031)
 Figure 64. Central and South America Perfluorodecalin for Ophthalmic Surgery Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 65. Central and South America Perfluorodecalin for Ophthalmic Surgery Sales Volume (K Units) by Application (2020-2031)
 Figure 66. Central and South America Perfluorodecalin for Ophthalmic Surgery Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 67. Brazil Perfluorodecalin for Ophthalmic Surgery Revenue (2020-2025) & (US$ Million)
 Figure 68. Argentina Perfluorodecalin for Ophthalmic Surgery Revenue (2020-2025) & (US$ Million)
 Figure 69. Middle East, and Africa Perfluorodecalin for Ophthalmic Surgery Sales YoY (2020-2031) & (K Units)
 Figure 70. Middle East and Africa Perfluorodecalin for Ophthalmic Surgery Revenue YoY (2020-2031) & (US$ Million)
 Figure 71. Middle East and Africa Top 5 Manufacturers Perfluorodecalin for Ophthalmic Surgery Sales Revenue (US$ Million) in 2024
 Figure 72. Middle East and Africa Perfluorodecalin for Ophthalmic Surgery Sales Volume (K Units) by Type (2021-2031)
 Figure 73. South America Perfluorodecalin for Ophthalmic Surgery Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 74. Middle East and Africa Perfluorodecalin for Ophthalmic Surgery Sales Volume (K Units) by Application (2020-2031)
 Figure 75. Middle East and Africa Perfluorodecalin for Ophthalmic Surgery Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 76. GCC Countries Perfluorodecalin for Ophthalmic Surgery Revenue (2020-2025) & (US$ Million)
 Figure 77. Turkey Perfluorodecalin for Ophthalmic Surgery Revenue (2020-2025) & (US$ Million)
 Figure 78. Egypt Perfluorodecalin for Ophthalmic Surgery Revenue (2020-2025) & (US$ Million)
 Figure 79. South Africa Perfluorodecalin for Ophthalmic Surgery Revenue (2020-2025) & (US$ Million)
 Figure 80. Perfluorodecalin for Ophthalmic Surgery Industry Chain Mapping
 Figure 81. Regional Perfluorodecalin for Ophthalmic Surgery Manufacturing Base Distribution (%)
 Figure 82. Global Perfluorodecalin for Ophthalmic Surgery Production Market Share by Region (2020-2031)
 Figure 83. Perfluorodecalin for Ophthalmic Surgery Production Process
 Figure 84. Regional Perfluorodecalin for Ophthalmic Surgery Production Cost Structure
 Figure 85. Channels of Distribution (Direct Vs Distribution)
 Figure 86. Bottom-up and Top-down Approaches for This Report
 Figure 87. Data Triangulation
 Figure 88. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

Perfluorodecalin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Ophthalmic Perfluorocarbon Liquids Market Research Report 2025
Global Ophthalmic Perfluorocarbon Tamponade Gas Market Research Report 2025
Perfluorocarbon Liquid for Eye Surgery Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Industrial Grade Perfluoro Propyl Vinyl Ether Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Data Center Fluorocarbon Coolant Market Research Report 2024
Industrial Grade Perfluoropropyl Vinyl Ether Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global 2 Perfluorohexyl Ethyl Methacrylate Market Research Report 2025
Global 3 Perfluorooctyl 2 Iodopropanol Market Research Report 2024
Global Perfluoro 2 methyl 3 pentanone Market Research Report 2025
Global 3 Perfluorooctyl Propanol Market Research Report 2024
Perfluorinated Carboxylic Acids PFCAs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Perfluorinated Surfactant Market Research Report 2024
Global Perfluoropolyethers Market Research Report 2025
Global Fluorinated Cooling Fluid for Data Center Market Research Report 2024
Global Perfluoropropylene Market Research Report 2024
Hexafluoropropylene Oxide HFPO Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Hexafluoropropylene Oxide Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Industrial Grade Perfluorohexyl Iodide Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Fluorocarbon Anthropoietic Blood Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Single-Port Vitrectomy Cutter Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13L12609
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Eye Ultrasound Biomicroscope Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32B20021
Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global Plano-Convex Laser Lenses Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-38C19846
Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global Heated Eye Masks Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-2H20253
Thu Nov 27 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions